Pediatric Metronidazole-Induced Encephalopathy: A Case Report and Review of the Literature

Abstract

Metronidazole-induced encephalopathy is a rare toxic encephalopathy secondary to the common use to this antimicrobial drug. It has been reported mainly in adult patients but only rarely in children. Owing to possible devastating complication of this disease, clinicians should have a higher index of suspicion for encephalopathic patients on metronidazole therapy. Here, we report a 5-month-old infant with metronidazole-induced encephalopathy presenting with nonconvulsive status epilepticus. A review of the literature in pediatric, as well as adult metronidazole-induced encephalopathy, is also provided.

Keywords

metronidazole - encephalopathy - nonconvulsive status epilepticus

Publication History

Received: 17 June 2020

Accepted: 30 July 2020

Article published online:
31 August 2020

• References

• 1 Löfmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis 2010; 50 (Suppl. 01) S16-S23
• 2 Roy U, Panwar A, Pandit A, Das SK, Joshi B. Clinical and neuoradiological spectrum of metronidazole induced encephalopathy: our experience and the review of literature. J Clin Diagn Res 2016; 10 (06) OE01-OE09
• 3 Sørensen CG, Karlsson WK, Amin FM, Lindelof M. Metronidazole-induced encephalopathy: a systematic review. J Neurol 2020; 267 (01) 1-13
• 4 Erdener SE, Kansu T, Arsava EM, Dericioglu N. Brain MRI evolution of metronidazole intoxication. Neurology 2013; 80 (19) 1816-1817
• 5 Metronidazole (Rx). Accessed August 11, 2020 at: https://reference.medscape.com/drug/flagyl-metronidazole-342566
• 6 Kafadar I, Moustafa F, Yalçın K, Klç BA. A rare adverse effect of metronidazole: nervous system symptoms. Pediatr Emerg Care 2013; 29 (06) 751-752
• 7 Omrani A, Rohani M, Hosseinpour S, Tavasoli AR. Persistent dystonia and basal ganglia involvement following metronidazole induced encephalopathy. Neurol Sci 2020; 41 (04) 957-959
• 8 Sun Y, Overby PJ, Mehta H. Case 271: metronidazole-induced encephalopathy. Radiology 2019; 293 (02) 473-479
• 9 Kuriyama A, Jackson JL, Doi A, Kamiya T. Metronidazole-induced central nervous system toxicity: a systematic review. Clin Neuropharmacol 2011; 34 (06) 241-247
• 10 El-Bitar MK, Boustany RM. Common causes of uncommon seizures. Pediatr Neurol 2009; 41 (02) 83-87
• 11 Cantador AA, Meschia JF, Freeman WD, Tatum WO. Nonconvulsive status with metronidazole. Neurohospitalist 2013; 3 (04) 185-189
• 12 Furukawa S, Yamamoto T, Sugiyama A. et al. Metronidazole-induced encephalopathy with contrast enhancing lesions on MRI. J Neurol Sci 2015; 352 (1-2): 129-131
• 13 Sudan YS, Garg A, Gupta R, Bansal AR. Headphone sign: metronidazole-induced encephalopathy. Neurol India 2016; 64 (06) 1374-1376
• 14 Hobbs K, Stern-Nezer S, Buckwalter MS, Fischbein N, Finley Caulfield A. Metronidazole-induced encephalopathy: not always a reversible situation. Neurocrit Care 2015; 22 (03) 429-436
• 15 Wakisaka K, Morioka T, Shimogawa T. et al. Epileptic ictal hyperperfusion on arterial spin labeling perfusion and diffusion-weighted magnetic resonance images in posterior reversible encephalopathy syndrome. J Stroke Cerebrovasc Dis 2016; 25 (01) 228-237